# The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

> **NCT04542733** · NA · RECRUITING · sponsor: **King Chulalongkorn Memorial Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Kidney Transplant Infection
- BK Virus Infection

## Interventions

- **DRUG:** Everolimus
- **DRUG:** reduced dose tacrolimus and Leflunomide

## Key facts

- **NCT ID:** NCT04542733
- **Lead sponsor:** King Chulalongkorn Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-10
- **Primary completion:** 2025-12-24
- **Final completion:** 2026-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542733, "The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04542733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*